USPTO 2015–2025 USPTO PatentsView US Corporation

Shifamed Holdings, LLC

USPTO PatentsView assignee record - 79 granted patents across 17 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Shifamed ranks #4,487 of 49,997 tracked US assignees by granted-patent volume, with 79 patents across 17 technology areas.

#4,487
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.7/100)
20.5
avg claims per patent
+308%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4487 · US Corporation #4,487 · 79 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 79 grants
  • TOP-DECILE #4,487/49,997
  • PHOTO-FINISH Ranpak
  • CPC-FOCUS A61F · 17 areas
  • INNOV-PAR 53.7/100
  • CLAIMS-DENSE 20.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +308% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ranpak Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Shifamed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Shifamed's Innovation Score is 53.7/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Shifamed's grants concentrate

Shifamed Holdings, LLC is a focused PatentsView assignee: 17 CPC subclasses with 59.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (14 grants) versus a trough of 1 in 2016. By volume, Shifamed sits between Ranpak Corp. and The University Court of the University of Edinburgh.

Shifamed's three-year grant acceleration

From 2019–2021 to 2022–2024, Shifamed Holdings, LLC moved from 20 to 35 grants (1.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Shifamed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Shifamed holds 79 patents at rank #4,489, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Shifamed

By rank, the assignees closest to #4,489 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Shifamed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shifamed, neither rank-band nor same-CPC leaders (those blocks stay above).

Shifamed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2016201720182019202020212022202320242025 18
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Shifamed Holdings, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 1.3%
2017 4 5.1%
2018 1 1.3%
2019 6 7.6%
2020 5 6.3%
2021 9 11.4%
2022 8 10.1%
2023 14 17.7%
2024 13 16.5%
2025partial year 18 22.8%

Which technologies does Shifamed Holdings, LLC patent most?

Top 15 of 17 technology areas

Where it ranks

Overall rank by patents

#4,487

of 49,997 tracked assignees

Innovation Score

53.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Shifamed Holdings, LLC's patent record in context - here's where to go next.

  • Shifamed Holdings, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 59.5% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #4,487 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Shifamed Holdings, LLC against Ranpak Corp., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.